1.
|
Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: SBG-2-03, EudraCT-number: 2008-002340-42, NCT00790322
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: SBG-2-01, NCT00533364
|
|
3.
|
Phase: Phase II Type: Treatment Status: Completed Age: Any age Sponsor: NCI, Other Protocol IDs: CDR0000378186, MSKCC-04050, NCT00089258
|
|
4.
|
Phase: Phase I Type: Treatment Status: Completed Age: Under 50 Sponsor: NCI Protocol IDs: MSKCC-01075, NCI-G02-2067, NCT00037011
|
|
5.
|
Phase: Phase I Type: Treatment Status: Completed Age: Under 22 Sponsor: NCI Protocol IDs: MSKCC-03095, NCT00087009
|
|
6.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: Any age Sponsor: NCI, Other Protocol IDs: CDR0000554434, MSKCC-05073, 05-073, NCT00492167
|
|
7.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: SBG-2-02, NCT00533728
|
|
8.
|
Phase: No phase specified Type: Diagnostic Status: Completed Age: 1 and over Sponsor: NCI Protocol IDs: 090109, 09-C-0109, NCT00923832
|